Ameriprise’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $711K | Sell |
2,395
-1,403
| -37% | -$454K | ﹤0.01% | 3440 |
|
|
2025
Q4 | $1.15M | Buy |
3,798
+958
| +34% | +$314K | ﹤0.01% | 3269 |
|
|
2025
Q3 | $968K | Buy |
2,840
+1,001
| +54% | +$304K | ﹤0.01% | 3379 |
|
|
2025
Q2 | $445K | Sell |
1,839
-4,076
| -69% | -$1,000K | ﹤0.01% | 3568 |
|
|
2025
Q1 | $1.61M | Buy |
5,915
+4,088
| +224% | +$956K | ﹤0.01% | 3006 |
|
|
2024
Q4 | $337K | Buy |
1,827
+8
| +0.4% | +$1.64K | ﹤0.01% | 3680 |
|
|
2024
Q3 | $408K | Sell |
1,819
-162
| -8% | -$29.1K | ﹤0.01% | 3557 |
|
|
2024
Q2 | $283K | Sell |
1,981
-539
| -21% | -$83.1K | ﹤0.01% | 3600 |
|
|
2024
Q1 | $394K | Sell |
2,520
-2,246
| -47% | -$362K | ﹤0.01% | 3499 |
|
|
2023
Q4 | $860K | Buy |
4,766
+535
| +13% | +$96.8K | ﹤0.01% | 3249 |
|
|
2023
Q3 | $761K | Buy |
4,231
+16
| +0.4% | +$3.17K | ﹤0.01% | 3255 |
|
|
2023
Q2 | $752K | Sell |
4,215
-45
| -1% | -$10.4K | ﹤0.01% | 3285 |
|
|
2023
Q1 | $918K | Sell |
4,260
-2,420
| -36% | -$580K | ﹤0.01% | 3195 |
|
|
2022
Q4 | $1.47M | Sell |
6,680
-4,008
| -38% | -$735K | ﹤0.01% | 2943 |
|
|
2022
Q3 | $1.46M | Buy |
10,688
+187
| +2% | +$32.1K | ﹤0.01% | 2937 |
|
|
2022
Q2 | $1.68M | Sell |
10,501
-394
| -4% | -$61.5K | ﹤0.01% | 2877 |
|
|
2022
Q1 | $2M | Sell |
10,895
-74,607
| -87% | -$15.9M | ﹤0.01% | 2914 |
|
|
2021
Q4 | $23.1M | Buy |
85,502
+6,495
| +8% | +$2.19M | 0.01% | 1303 |
|
|
2021
Q3 | $28.7M | Sell |
79,007
-3,244
| -4% | -$1.06M | 0.01% | 1031 |
|
|
2021
Q2 | $28.2M | Sell |
82,251
-150
| -0.2% | -$49.7K | 0.01% | 1109 |
|
|
2021
Q1 | $28.7M | Sell |
82,401
-6,260
| -7% | -$2.07M | 0.01% | 1063 |
|
|
2020
Q4 | $22.9M | Sell |
88,661
-31,571
| -26% | -$8.69M | 0.01% | 1142 |
|
|
2020
Q3 | $34.4M | Sell |
120,232
-32,696
| -21% | -$7.68M | 0.01% | 795 |
|
|
2020
Q2 | $28.8M | Buy |
152,928
+16,816
| +12% | +$2.74M | 0.01% | 866 |
|
|
2020
Q1 | $16.8M | Sell |
136,112
-107,929
| -44% | -$16.9M | 0.01% | 1047 |
|
|
2019
Q4 | $40.5M | Sell |
244,041
-145,488
| -37% | -$24.2M | 0.02% | 792 |
|
|
2019
Q3 | $47.7M | Buy |
389,529
+37,184
| +11% | +$4.94M | 0.02% | 681 |
|
|
2019
Q2 | $43.7M | Sell |
352,345
-5,051
| -1% | -$641K | 0.02% | 738 |
|
|
2019
Q1 | $47.2M | Sell |
357,396
-16,330
| -4% | -$2.2M | 0.02% | 679 |
|
|
2018
Q4 | $52.4M | Buy |
373,726
+156,536
| +72% | +$20.8M | 0.03% | 595 |
|
|
2018
Q3 | $37.5M | Buy |
217,190
+63,692
| +41% | +$10.7M | 0.01% | 898 |
|
|
2018
Q2 | $23.6M | Buy |
153,498
+152,087
| +10,779% | +$27.1M | 0.01% | 1059 |
|
|
2018
Q1 | $237K | Buy |
+1,411
| New | +$191K | ﹤0.01% | 3428 |
|
Other funds holding ONC
BBA
HA
Ameriprise's ONC Position: Q1 2026 in Review
Ameriprise reduced its BeOne Medicines Ltd (ONC) stake by 37% in Q1 2026, selling an estimated $454K and leaving 2,395 shares worth $711K. The position accounts for ﹤0.01% of the portfolio, ranked #3440.
Ameriprise first reported a position in ONC in Q1 2018 and has held it in 33 quarters since. The position peaked at $52.4M in Q4 2018. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.
- Ameriprise held 2,395 shares of BeOne Medicines Ltd worth $711K as of Q1 2026.
- Ameriprise sold 1,403 BeOne Medicines Ltd shares in Q1 2026, an estimated $454K.
- BeOne Medicines Ltd made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3440 holding.
- Ameriprise first reported a position in BeOne Medicines Ltd in Q1 2018 and has held it in 33 quarters since.
- Ameriprise's BeOne Medicines Ltd position peaked at $52.4M in Q4 2018.
- 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.